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Abstract
Background: Multicellular spheroids, an appropriate in vitro system for simulating 3-D tumor micro-milieu can be used for
evaluating and predicting tumor response to therapeutic agents including metabolic inhibitors. However, detailed understanding
of the nature, distribution and sensitivity/responses of cellular sub-populations to potential therapeutic agents/strategies is
required for using this unique model with optimal precision. Spheroid characteristics may also vary considerably with the origin
and type of cell line used, and thorough characterization of viable and dissociated glioma cell spheroids is not yet completely
known. In order to evaluate in vivo responses of gliomas to various therapeutic strategies, especially the metabolic inhibitors
capable of penetrating the blood brain barrier, we have characterized continuously growing spheroids of a human glioma cell
line (BMG-1) with respect to organization, growth, viability, cell survival, cell death, metabolic and mitochondrial status, oxidative
stress and radiation response using microscopy, flow cytometry and enzymatic assays. Spheroids were fed daily with fresh
medium in order to maintain nutrient supply to outer cellular layers while hypoxia/necrosis developed in the innermost cells of
enlarging spheroids.
Results: Volume of spheroids, fed daily with fresh medium, increased exponentially during 7–28 days of growth through three
population doublings. Proportion of G1-phase cells was higher (~60%) than exponentially growing monolayer cells (~48%). A
significant fraction of S-phase cells turned metabolically inactive (disengaged in DNA synthesis) with increasing age of the
spheroids, unlike in quiescent monolayer cultures, where the fraction of S-phase cells was less than 5%. With increasing spheroid
size, increasing sub-populations of cells became non-viable and entered apoptosis or necrosis revealed by Annexin-V-FITC/PI
staining. PI positive (necrotic) cells were not confined to the centre of the spheroid, but distributed at certain discrete foci.
Average glucose consumption and lactate production were 2–3 folds higher in viable spheroid cells compared to monolayer
cells, implying a compensatory increase in glycolysis possibly due to hypoxic environment. HIF-1α was expressed only in
spheroids and increased in an age-dependent manner, whereas c-Myc (known to induce apoptosis in glucose-deprived cells)
levels were three times higher than monolayer cells. Mitochondrial mass and activity decreased significantly during first 14 days
of growth but increased with age, and were not associated with increase in ROS levels. Bcl-2 and Bax levels were higher (~2
folds) than monolayers, while the ratio (Bcl/Bax) remained unaltered. Radiation-induced oxidative stress was considerably less
in spheroids as compared to monolayers, and corresponded well with increase in radioresistance demonstrated by the
clonogenic assay, similar to hypoxia induced radioresistance observed in tumors.
Conclusion: Development of S-negative cells and reduced endogenous and radiation-induced ROS coupled with higher levels
of anti (Bcl2) as well as pro (Bax) apoptotic regulators observed in spheroids suggest the intricate/complex nature of
endogenous as well as induced stress resistance that could exist in tumors, which contribute to the treatment resistance.
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Background
Cells of actively growing tumors are exposed to varying
micro-environmental conditions due to non-homogene-
ous vascular supply [1], leading to the development of
localized regions in tumors having low oxygen tension,
low glucose concentration and acidic extracellular pH due
to accumulation of metabolic by-products such as lactic
acid. As a result, cells in these regions are exposed to vary-
ing levels of hypoxia, anoxia and acidosis [2]. From the
radiobiological point of view, hypoxic cells constitute the
most important cellular subpopulation because they are
more radioresistant than the euoxic cells as a result of
reduced generation of radiation-induced reactive oxygen
species or ROS [3,4]. The hypoxic cell fraction increases
considerably with the advancement of tumor size and
grade offering significant resistance to radiotherapy. The
currently used hypoxic cell sensitizers (nitroimadazole
compounds) have met with limited success due to the lack
of differential effect besides systemic toxicity. Therefore,
there is a need to develop effective strategies to selectively
enhance the radiosensitivity of these cells, which requires
a detailed characterization of the nature and responses of
these resistant cellular fractions. Since hypoxic cells exist
in three-dimensional tumors that behave as heterogene-
ous systems demonstrating alterations in many vital gen-
otypic and phenotypic characteristics regulating various
biological processes, an in vitro cellular model that closely
simulates these conditions is essential for carrying out
studies on hypoxic cell and tumor responses to therapeu-
tic agents.
Monolayer cultures of established cell lines from human
tumors have been widely used for studying the various
molecular processes including the identification of spe-
cific molecular lesions related to the dysregulation of cell
proliferation and cell death, the two important functional
targets for the development of therapies. Unfortunately,
investigations necessary for the development and/or eval-
uation of some of the therapeutic strategies cannot be car-
ried out with this most widely used laboratory system,
since complexities arising out of 3-dimensional organiza-
tion of solid tumors (viz., cell-cell/cell-matrix interactions
and variations in vasculature and nutrient supply) result-
ing in subtle changes in phenotypic expression (especially
the metabolic changes) are not provided in the monolayer
cultures derived from tumor cells. In contrast, multicellu-
lar spheroids of tumor cells provide an excellent three-
dimensional in vitro model in which hypoxic conditions
can be generated to facilitate detailed investigations
including the response to various chemical agents and
radiation [5,6].
Spheroids are characterized by high cell-density and a
closely packed, 3-D tumor like structure, which leads to
severe diffusion limitations for molecules as small as glu-
cose and oxygen, thereby creating heterogeneous cell sub-
populations of actively proliferating as well as quiescent,
hypoxic and necrotic cells as found in solid tumors [7].
Available evidences suggest that low concentration of glu-
cose and oxygen in the inner regions of spheroids may
contribute to the formation of quiescent, hypoxic, anoxic
and necrotic cell sub-populations [8-10]. Characterization
of the nature of these cell sub-populations as well as their
responses to radiation and radiomodifying agents can
help in the development of more effective radiosensitiz-
ing strategies. For example, hypoxic cells are known to
derive a large part of their energy from glucose-dependent
anaerobic metabolic pathways. Therefore, inhibitors of
glycolysis could specifically modify the responses of this
resistant sub-population of cancer cells. A number of in
vitro studies have indeed shown that 2-DG, a glucose ana-
logue and inhibitor of glycolytic ATP production [11-13],
selectively inhibits energy-dependent DNA repair and cel-
lular recovery processes in cancer cells [14-16] resulting in
enhanced cell death [11,13,17,18]. Spheroids could serve
a very useful model to understand further the mecha-
nisms of radiosensitivity induced by this glycolytic inhib-
itor in solid tumors, since spheroids mimic the solid
tumors more closely than the monolayer culture.
Spheroids have been used for a broad spectrum of studies
in cancer biology and employed extensively in radiobio-
logical investigations [19] as they provide a good in vitro
system to mimic the radioresistant hypoxic cell popula-
tion generally found in tumors. Unfortunately however,
detailed information available on the intercellular varia-
tion in mitochondrial mass, activity and ROS levels (oxi-
dative stress mainly responsible for damage induced by
low LET radiation) as a function of spheroid growth and
with reference to other parameters like viability cell death
etc in culture is lacking. These parameters influence the
end results of in vitro studies aimed at understanding
tumour response to various cytotoxic agents and meta-
bolic inhibitors. Therefore, the present study was under-
taken to systematically characterize spheroids established
from a human glioma cell line BMG-1 [11,20] with
respect to organization, growth, viability and cell survival,
cell death, metabolic and mitochondrial status, oxidative
stress and radiation response with age and spheroid size
using microscopy, flow cytometry and enzymatic assays.
The results of the present studies demonstrate develop-
ment of S-negative cells, reduced endogenous and radia-
tion-induced ROS besides changes in levels of anti (Bcl2)
as well as pro (Bax) apoptotic regulators observed in sphe-
roids which suggest the intricate/complex nature of
endogenous as well as induced stress resistance that could
exist in tumors, which contribute to the treatment resist-
ance.Journal of Translational Medicine 2006, 4:12 http://www.translational-medicine.com/content/4/1/12
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Results
Growth
The growth of spheroids was monitored by measuring the
volume and surface area of at least 50 spheroids at inter-
vals of 7 days. The initial aggregation of monolayer cells
plated for spheroid formation lasted for three days.
Within 6–7 days the small clumps were replaced by com-
pact spheroids with a radius of 80–100 micro meters. The
volume vs. time plot of spheroids showed an exponential
growth pattern of spheroids (Fig 1) till 28 days. Unlike
spheroids from other cell lines, BMG-1 spheroids did not
show any plateau phase in the growth curve as they disin-
tegrated between 27–29 days, thereby necessitating a
detailed characterization before initiating any further
work. Despite this exponential increase in size, the phase
contrast images acquired at different time intervals (3, 7,
14 and 28 days) showed an enhanced proportion of dead
cells at the center of spheroids, which increased with age
(Fig 2). The viability (assessed using trypan blue dye
exclusion assay) decreased from 93% in 7-day-old sphe-
roid to 70% in the 28-day-old spheroids. The clonogenic
potential (plating efficiency) also decreased from 65% in
the 7-day-old spheroids to 25% in the 28-day-old sphe-
roids, indicating an increase in cell death with age (Table
1). This is in contrast to the plating efficiency of the mon-
olayer BMG-1 cells, which was 85% as reported earlier
[21].
Cell cycle distribution
To determine whether the cessation of cell growth in the
spheroid culture was similar to the arrest of cells in a par-
ticular phase of the cell cycle as is generally observed in
the stationary monolayer, we analyzed the fraction of
active S-phase cells (BrdU label) and the DNA content by
the flow cytometry. Fig 3 shows bivariate flow cytometric
dot plots of DNA vs BrdU for BMG-1 monolayers and
spheroidal cells showing cell cycle distribution of cells
labelled with BrdU. Interestingly, a consistently higher
proportion of cells were in G1 phase (60%) and signifi-
cantly reduced S phase (20%) and G2 phase (20%) was
observed throughout the growth of the spheroids (7–28
days) as compared to monolayers (G1 50%, S 40% and
G2M 12%) in exponential phase. In spite of S phase being
constant, the percent of BrdU positive cells (actively pro-
liferating cells) decreased drastically from 18% in 7 day
old spheroid to 5% in 28 day old spheroid. However there
was an increase in S0 cell population (quiescent S phase
cells) with the age of spheroid in culture, therefore, show-
ing constant S phase cells throughout the growth of sphe-
roid in culture (Table 2).
Cell death
Staining with annexin V has been used as a specific marker
for cells in the early phase of apoptosis where the cell
membrane is still intact. Asymmetry of plasma membrane
that often occurs during apoptosis is mainly due to the
translocation of phosphotidyl serine from inner leaflet of
the membrane to the outer surface of the cell revealed by
the binding of Annexin V [22]. On the other hand, non-
specific membrane damage is associated with necrotic
death indicated by permeability to PI. To characterize the
nature of cell death, we analyzed the spheroids for the
presence of apoptotic and necrotic, the two main forms of
Spheroid growth Figure 1
Spheroid growth. Growth of the BMG-1 spheroids 
revealed by the increase in the volume of spheroids as a func-
tion of time.
Table 1: Spheroid size and cellular characteristics as a function of age in spheroids.
Age of 
spheroids in 
days
Radius (µm) Av. volume × 
10-6(µm3)
Avg. No. of 
cells/spheroid
Avg. Cellular 
Diameter (µm)
Cell packing 
density
Viability (%) Plating 
Efficiency (%)
7 93 ± 5 3244 1176 ± 39 13 ± 1 0.36 98 ± 1.4 65 ± 0.6
14 148 ± 10 13300 2222 ± 47 7 ± 1(20%); 14 
± 1
0.17 78 ± 1.9 63 ± 0.2
21 157 ± 11 15896 4236 ± 63 10 ± 1 (25%); 
16 ± 1 (63%); 
24 ± 2 (12%)
0.27 77 ± 1.7 45 ± 0.2
28 242 ± 19 57891 8975 ± 78 19 ± 2 0.16 70 ± 3.2 25 ± 0.1
Note: All values are mean ± SD of 20–50 observations from each experiment (radius, surface area, volume, Number of cells/spheroid and average 
size of cells) or 6 observations (viability and plating efficiency) from three experiments.Journal of Translational Medicine 2006, 4:12 http://www.translational-medicine.com/content/4/1/12
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cell death. Dual staining with Annexin V FITC and PI
clearly showed an increase in Annexin positive and PI pos-
itive cells indicating accumulation of apoptotic as well as
necrotic cells with age upto 21 days (Fig 4). Interestingly,
however the fraction of Annexin-V positive cells decreased
significantly at 28 days, while a profound increase in the
necrotic cell population (PI positive cells; >78%) was evi-
dent. These changes in the fraction of dead cells (apop-
totic and/or necrotic) correlated reasonably well with the
fraction of clonogenically viable cells (Table 1).
Glucose usage and lactate production
Development of hypoxic regions with increase in sphe-
roid cells is expected to result in enhanced glucose usage
and anaerobic glycolysis, partly responsible for alterations
in oxidative status, therefore, glucose usage and lactate
production in BMG-1 spheroids and monolayers were
studied by estimating the residual glucose and the lactate
production at the end of 2-h incubation in HBSS. In the 7-
day old spheroids, the glucose consumption (2.1 p mole/
cell/h) as well as lactate production (3.67 p mole/cell/h)
Age dependent cell viability Figure 2
Age dependent cell viability. Photomicrographs of unfixed spheroids showing increase in size and dead cell population. 
Panel A: Bright field images of unstained spheroids. Panel B: Propidium iodide stained spheroids.
Table 2: Comparison of cell cycle distribution in exponentially growing monolayers and spheroids studied as a function of age.
Age of spheroids in 
days
G0/G1 Total S Phase Cells S-Positive Cells S-Negative Cells G2/M
Monolayers 48 ± 3 40 ± 1 40 ± 1 0 12 ± 1
Plateau 72 ± 2 3 ± 2 3 ± 2 0 25 ± 4
07 59 ± 2 20 ± 3 18 ± 3 2 ± 0.5 21 ± 2
14 59 ± 2 20 ± 1 9 ± 1 11 ± 1 21 ± 1
21 56 ± 3 19 ± 2 6 ± 2 13 ± 1 25 ± 3
28 58 ± 4 19 ± 1 5 ± 1 14 ± 1 23 ± 1
Note: All values are mean ± SD of 3 observations from three experimentsJournal of Translational Medicine 2006, 4:12 http://www.translational-medicine.com/content/4/1/12
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was nearly 2–3 fold higher than the monolayer cells (0.83
& 1.47 p mole/cell/h respectively, (Table 3), clearly sug-
gesting a relatively more hypoxic environment in the
spheroids. Growth of spheroids upto 28 days yielded fur-
ther increase in lactate production, resulting in a signifi-
cant reduction in pH of growth medium (data not
shown), thereby resembling the intratumoral acidic con-
dition.
Alterations in HIF-1α, c-Myc, Bcl2 and Bax protein levels
Since the glucose utilization and lactate production was
significantly higher in spheroids as compared to monol-
ayers and hypoxia could be one of the contributing factors
for enhanced glycolysis, we examined the levels of HIF-1α
in these two model systems using immunoblotting. As
expected, the HIF-1α could not be found in the monol-
ayer cultures, while age-dependent increase in its level was
evident in the spheroidal cells (Fig. 5), suggesting thereby
that the enhanced glycolysis could be partly due to HIF-1α
induced over expression of certain glycolysis-related genes
on account of hypoxia. These observations are in agree-
ment with the earlier findings showing the presence of
hypoxic cells in spheroids [5]. Stress-induced apoptosis
(particularly glucose deprivation) in cells with up-regu-
lated glycolysis has been shown to be mitochondrial
dependent, mediated by c-Myc, and regulated further by a
balance between the anti- and pro-apoptotic proteins Bcl2
and Bax. Since we observed increasing fraction of apop-
totic cells with age in spheroids, we examined the levels of
these proteins. The c-Myc levels were clearly higher in
spheroidal cell population as compared to monolayers,
indicating that spheroids were more prone to apoptosis/
necrosis under conditions of glucose deprivation.
Although the levels of Bax and Bcl-2 were upregulated in
the spheroids (Fig 5), the ratio of Bcl2/Bax (measured by
flow cytometer), a possible regulator of the release of cyto-
chrome c (the activator of apoptosis causing caspases),
was not significantly different in both the models (data
not shown).
Radiation response
Radiation dose response was studied by analyzing the clo-
nogenic cell survival using the macrocolony assay. Sphe-
roids at both the ages (7 & 28 days) were found to be more
resistant than the monolayer cells (Fig 6), with the values
of Dq and D0 as well as SF2 being significantly higher in the
spheroids (1.8, 3.2 and 0.9 respectively on day-7) as com-
pared to monolayers (1.2, 2.4 and 0.8) (Table 3).
Endogenous and ionizing radiation induced ROS 
generation in spheroids
Reactive oxygen species act as mediators of radiation-
induced cell damage. To determine the radiation-induced
ROS generation in monolayers and spheroids, small non-
necrotic as well as large spheroids containing central
necrotic region were stained with the redox sensitive dye
H2DCFDA and the fluorescence of ROS converted DCF
was monitored by flow cytometry. Although endogenous
levels were similar, the radiation-induced ROS generation
was significantly higher in exponentially growing monol-
ayer cells than in spheroids. The ROS levels decreased fur-
ther with increase in spheroid size. Furthermore, the
monolayer cells showed a bimodal distribution of values
for ROS levels, while the spheroidal cell population was
unimodal with wide variation in the ROS level (Fig 7A). A
dose-dependent (0–10 Gy) increase in the amount of ROS
was observed in the irradiated monolayers and 7-day-old
spheroids (Fig 7B). However both endogenous as well as
the radiation-induced ROS were reduced with increasing
age of spheroids (Fig 7B). These results indicate that
decrease in the levels of intracellular ROS could be a
major contributing factor for radioresistance displayed by
spheroids.
Cell cycle distribution Figure 3
Cell cycle distribution. Cell cycle distribution of BMG-1 
spheroids and monolayer cells.Journal of Translational Medicine 2006, 4:12 http://www.translational-medicine.com/content/4/1/12
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Mitochondrial status
Mitochondria are the main site of ROS generation in the
cell with 2% of oxygen consumed being leaked into cyto-
plasm as ROS. Since ROS generation in spheroids showed
significant differences, we investigated the mitochondrial
status using flow cytometric analysis following staining
with NAO and Rh123. NAO accumulates in mitochondria
independent of the status of mitochondrial membrane
potential. Therefore, cells having more number of mito-
chondria will show an increase in the relative fluorescence
intensity, which was collected on the log scale during flow
cytometric measurements. While the MFI of monolayer
cells was 740, the MFI was much lower in the 7, 14 and 28
day old spheroids, i.e., 422, 94, 274 respectively, showing
a 2 to 8 fold decrease in the mitochondrial mass per cell
(Fig 8a). This reduction in the number of mitochondrial
mass in spheroidal cells corresponds well with reduction
in ROS generation with increase in the age of spheroid.
Rh-123 is a cell-permeant cationic fluorescent dye that is
readily sequestered by functionally active mitochondria
having intact membrane potential. Relative fluorescence
intensity of the spheroids significantly decreased signifi-
cantly at 7 and 14 days as compared to the monolayers
(Fig 8b). This was followed by an abrupt increase in the
mitochondrial activity in the 28-day-old spheroids,
although the mitochondrial mass did not increase.
Discussion
Appropriate in vitro models play a vital role in understand-
ing various molecular processes underlying tumor biology
besides the development and evaluation of new therapeu-
tic agents and strategies for improving cancer therapy.
Spheroids are in vitro 3-D model that simulates tumor
micro-milieu and have been vastly used to understand dif-
ferent aspects of tumor biology. Therefore in vitro models
that permit reproducible experimental studies are
expected to greatly facilitate the development of newer
and effective therapeutic strategies. We discuss here some
of the aspects of a spheroid model developed from a
human glioma cell line (BMG-1), particularly with respect
to the nature and distribution of various spheroidal cell
populations with increasing age and size of spheroids to
understand their behaviour, particularly related to the
metabolism and radiation response.
Spheroid growth and appearance of S-phase quiescent (S0) 
cells
Spheroids are a three-dimensional cellular system that
closely simulates conditions existing in the under-per-
fused solid tumors wherein cellular heterogeneity devel-
ops due to increasing distances from the nourishing blood
capillaries [23]. In the present study, spheroids grown
from an established human glioma cell line (BMG-1)
showed an exponential growth pattern up to 28 days in
culture, followed by rapid disintegration. While spheroids
had a consistently higher proportion of G1 population as
compared to monolayers (Table 2), their cell cycle distri-
bution (G0/G1, S and G2/M phases) did not vary with
growth between 7 and 28 days, except that the fraction of
S-phase cells actively synthesizing DNA (S-positive cells)
Table 3: Comparision of glucose usage lactate production and radiation response in the exponentially growing monolayers and as a 
function of age in spheroids.
Model Glucose utilization 
(pico mole/cell/h)
Lactate production 
(pico mole/cell/h)
Dq(Gy) D0(Gy) S.F2
Monolayer 0.83 ± 0.03 1.47 ± 0.01 1.2 2.4 0.8 ± 0.04
7 day spheroid 2.10 ± 0.07 3.67 ± 0.04 1.8 3.2 0.9 ± 0.03
28 day spheroid 1.85 ± 0.05 2.93 ± 0.02 2.8 2.7 1.0 ± 0.06
Note: All values are mean ± SD of 6 observations from two experiments
Apoptotsis by flow cytometry Figure 4
Apoptotsis by flow cytometry. Bivariate plots of Propid-
ium iodide staining (revealing non-specific membrane dam-
age) and Annexin V binding (PS externalization) studied by 
flow cytometry showing the dynamics of apoptotic cells as a 
function of age in culture.Journal of Translational Medicine 2006, 4:12 http://www.translational-medicine.com/content/4/1/12
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reduced drastically from 18% on day-7 to 5% on day-28,
with the total S-phase population remaining nearly
unchanged at 20% (Fig 3, Table 2). This was in contrast
with the monolayer cultures wherein all the S phase cells
were S positive even as they reached quiescence (Fig 3,
Table 2). Cells in the spheroids are known to accumulate
in a quiescent state as the growth advances [2,23,24], pre-
sumably due to micro-environmental stresses such as dep-
rivation of growth factors [25] and/or nutrients [26] or the
production of inhibitory factors [24,27] induced within
the mass of spheroids. In the present study, S-phase quies-
cence was observed despite a consistent cell proliferation
and exponential increase in spheroid volume up to 28
days (Table 1). It appears, therefore, that spheroid-specific
factors like hypoxia and intercellular interactions that are
different as compared to the monolayer culture mimic the
conditions in large solid tumors, which result in a differ-
ent type of quiescence. In contrast with the previously
reported studies, we replenished the medium daily as our
spheroids were unstable if not fed for long intervals of
time. Regular replenishment of medium may closely
resemble in vivo conditions in which tumor cells having
sufficient vascular supply continuously receive fresh nutri-
ents.
Cell cycle distribution and radioresistance
It is pertinent to note here that the cell cycle distribution
at the time of irradiation is an important determinant of
cell survival. Cells show considerable amount of variation
in the radiosensitivity as a function of their position in the
cell cycle, with S phase cells being more resistant, while
cells in the G2 and M are most sensitive. However, the rel-
ative radioresistance of spheroids (Table 3) could not be
attributed to this phenomenon, as the fraction of cells in
the relatively resistant S-phase was lower (~20%) in sphe-
roids as compared to the monolayer cells (~40%). Further
it is also interesting to note that the fraction of S positive
cells (actively engaged in DNA synthesis, generally effi-
cient in DNA repair) also decreased from 18% at day 7 to
5% at day 28 (Table 2) in the spheroids, while the Dq val-
ues increased from 1.8 to 2.8 under these conditions.
Variations in cell size and cell packing density
Earlier studies have generally assumed the cell packing
density to be constant throughout the growth of sphe-
roids, and the cell population doubling time has been
considered same as the volume doubling time [28]. How-
ever, our results clearly show that assuming a constant cell
density may not be appropriate especially when the sphe-
roid is cultured for long intervals of time (four weeks in
this case) and/or when they are slow growing. The average
cell packing density decreased from 0.36 to 0.16 with the
growth of spheroids from 7th day to 28th day, associated
with a significant increase in the average size of cells
(Table 1). Therefore, the cellular load inferred from mere
volume measurements during spheroid growth could be
misleading.
Incidence of cell death versus cellular radioresistance
Cell survival under conditions of hypoxic stress depends
on the glycolytic status of cells [29] and the cellular resist-
ance to hypoxia-induced apoptosis [30]. A decrease in the
clonogenicity (plating efficiency) and viability was gener-
ally observed with increase in the size of spheroids (Table
I), which could be associated with the induction of pro-
grammed cell death or necrosis. The Annexin-V labeling
assay revealed the presence of secondary necrotic (Ann-
V+ve/PI+ve) cells in the absence of apoptotic (Ann-V+ve/PI-
ve) cells on days 7, 21 & 28, indicating that apoptosis may
be a rather quick process in these cells, obscuring the
detection of early stages.
Interestingly, although the plating efficiency was signifi-
cantly reduced (25%) in the 28-day spheroids, the sur-
vival curve suggested a very high radioresistance of the
surviving spheroid cells (Table 1 &3). However, these sur-
viving cells did not belong to a specific cell-cycle phase
(Table 2), implying the involvement of metabolic or other
processes in radiation resistance.
Enhanced glycolysis, hypoxia and radiation resistance
Many factors associated with hypoxia and related altera-
tions in the metabolism have profound influence on the
radiation response of cells. For example, hypoxic tumor
Protein analysis Figure 5
Protein analysis. Western blots analyses of different pro-
teins Bcl2, Bax, c-Myc and HIF-1α in BMG-1 monolayers and 
spheroids.Journal of Translational Medicine 2006, 4:12 http://www.translational-medicine.com/content/4/1/12
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cells generally show resistance to low LET radiation (X-
rays), which has been suggested to be primarily due to the
reduced radiation-induced ROS generation, responsible
for the cell death through the induction of macromole-
cule damage, mainly in the form of DNA strand breaks
[31]. However, enhanced anaerobic glycolysis, leading to
accumulation of lactate may also facilitate recovery proc-
ess as shown in the monolayer cells held for a few hours
in high lactate medium [32,33]. In the present study, glu-
cose utilization as well as lactate production was 2–3 fold
higher in the spheroids, (Table 3) with a corresponding
increase in the resistance to radiation-induced cell death
(Table 3, Fig 6) as compared to the monolayer cultures.
However, a distinct increase in the lactate production
could not be observed in 7 day old spheroids, in-spite of
Hif induction (Fig. 5), which is rather surprising and
needs further investigations including the analysis of
LDH. These results also suggest that, concomitant to the
development of spheroid (which results in an altered cell-
to-cell interaction as compared to the monolayers); there
is alteration in the pattern of metabolism with further
increase in glucose dependence.
Glucose usage observed in tumors often correlate with
resistance to therapy and poor prognosis [34,35]. Further,
we have recently observed that the radiosensitization by
2-deoxy-D-glucose (2-DG), an inhibitor of glucose trans-
port and glycolysis, was 2–3 folds higher than in monol-
ayers cells, which correlated well with the difference in
glucose usage between the two systems [36]. This
enhanced glucose usage and lactate production (anaero-
bic glycolysis) could be on account of compensatory
increase in the constitutive level of expression of glycolytic
enzymes, leading to a high rate of glycolytic capacity [37].
The activity of hexokinases is highly elevated in rapidly
growing tumors as compared to normal cells [38-40]. The
oxygen sensor HIF-1α also induces the expression of
genes that encode glycolytic enzymes like aldolase A,
enloase 1, lactate dehydrogenase A, phosphofructokinase
L, phosphoglycerate kinsae 1, and pyruvate kinase M.
Therefore, we investigated alterations in the levels of HIF-
1α in the cells throughout the spheroid growth up to 28
days. Indeed we found a higher level of HIF-1α (Fig 5)
despite daily feeding of fresh medium to the spheroids,
similar to the results reported previously in the unfed
spheroids [23], thereby suggesting that the enhanced gly-
colysis observed in spheroids could be mainly driven by
hypoxia, and might be induced by the over-expression of
genes encoding proteins involved in glucose metabolism.
The gene for LDH-A, whose expression is often increased
in cancer cells, has been identified as a c-Myc responsive
gene [41], and is also shown to be induced by hypoxia
through the activity of HIF-1α [42]. Moreover, c-Myc and
HIF-1α binding sites resemble the carbohydrate response
element [43-45]. Cells over-expressing c-Myc have been
shown to be more susceptible to the induction of apopto-
sis under stress induced by certain agents as well as in the
sub-optimal growth conditions [46,47]. Therefore, we
investigated the level of c-Myc, and indeed observed a
three-fold higher level in the spheroidal cells as compared
to the monolayer (Fig 5), implying that these cells might
be more susceptible to apoptosis and necrosis induced by
glucose deprivation.
Mitochondrial activity and generation of reactive oxygen 
species
Low-LET ionizing radiation produces damage to cellular
biomolecules mainly through the generation of ROS initi-
ated by hydroxyl radicals. Apart from hypoxic cell popula-
tion, enhancement of glycolysis in spheroid cells (as
evident from increased glucose usage and lactate produc-
tion) would result in the reduced generation of ROS fol-
lowing radiation exposure. Studies using confocal
microscopy have shown that alterations in ATP level influ-
ences the generation of ROS in a concentration-depend-
ent manner [48]. We did not observe any significant
difference between the monolayers and spheroids of all
ages with respect to the endogenous levels of ROS (Fig
7A).
The ROS generation may be reduced through partial
uncoupling of oxidative phosphorylation and by decreas-
ing the transmembrane potential and the redox state of
complex 1 [49]. This is achieved by increasing permeabil-
ity of the inner mitochondrial membrane to K+ and H+ by
means of opening mitochondrial K+  channels or by
endogenous uncoupling proteins like carnitine palmitoyl
tranferases CPT I and II [50], thereby reducing the mito-
chondrial membrane potential as seen in spheroids from
7 days to 21 days in culture when compared to monolay-
Radiation dose response Figure 6
Radiation dose response. Radiation dose response of cell 
survival of BMG-1 spheroids and exponentially growing mon-
olayer cells.Journal of Translational Medicine 2006, 4:12 http://www.translational-medicine.com/content/4/1/12
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ers (Fig 8b). Radiation induced ROS was 2–3 times less in
the spheroids as compared to the monolayer cells at all
the three absorbed doses, and this could be partly respon-
sible for the radioresistance exhibited by the spheroidal
cells (Fig 7B). However, increase in ROS most often occurs
during the later stages of cell death program where
cytoskeletal reorganization as well as disintegration takes
place. Further, the level of intracellular ROS to a great
extent determines the mode of cell death; low levels of
ROS inducing PCD while high levels promotes necrosis or
can lead PCD-committed cells towards necrotic-like
destruction [51]. While the anti-apoptotic processes and
regulators are induced to maintain the homeostasis to a
certain extent (the most important family of protein being
Bcl-2), alternative pathways might also be responsible for
inducing apoptosis and/or necrosis.
Conclusion
In summary, the present study provides a detailed charac-
terization of multicellular spheroids with respect to a
number of parameters relevant to studies aimed at evalu-
ating efficacy of tumor therapeutic agents. Characteriza-
tion of mitochondrial status and oxidative stress levels
with the increasing age of multicellular spheroids, cou-
pled with enhanced glycolysis and related variations in
HIF-1α and c-Myc will prove useful in optimizing the use
of this valuable cellular 3-D tumor model for predicting
tumor response to chemotherapeutic/radiosensitizing
agents acting on metabolic pathways. In this study, sphe-
roids were regularly fed with fresh medium, which may
resemble the in vivo conditions wherein a proportion of
cells receive uninterrupted supply of nutrients and oxygen
while others become hypoxic and may enter secondary
necrosis. Investigations using spheroid model also high-
light the inherent limitations of extrapolations made from
monolayer studies for application in tumor biology and
therapy. The detailed characterization presented here is
aimed at obtaining a better understanding of the spheroid
model for optimizing and interpreting the predictive ther-
apy trials and drug response of various therapeutic agents
and/or adjuvants, particularly metabolic modulators.
Methods
Monolayer culture
The cerebral glioma cell line (BMG-1; wild type p53) was
established in Bangalore, India (20). Stock cultures were
maintained in the exponentially growing state by passag-
ing twice weekly in DMEM containing 10 mM HEPES and
antibiotics supplemented with 5% fetal bovine serum.
Spheroid culture
BMG-1 spheroids were grown by inoculating 1 × 106 via-
ble cells of BMG1 in non-adherent 90-mm petridishes in
10 ml DMEM supplemented with 5% fetal calf serum,
antibiotics and 10 mM HEPES. Clusters of cells could be
observed after 24 hours of initiation. However, it took
nearly 4 days for these clusters to form spheroids (clusters
could not be dislodged by pipetting). Approximately
10,000 spheroids could be obtained in a petridish of ~60
Oxidative stress by flow cytometry Figure 7
Oxidative stress by flow cytometry. (A) Generation of 
ROS measured by H2DCFDA technique in BMG-1 monolay-
ers and spheroids. Untreated control (a), 2 Gy (b), 5 Gy (c) 
and 10 Gy (d). (B) Dose response of ROS generation in mon-
olayers and spheroids. Average values of the mean fluores-
cence intensities (MFI) of H2DCFDA were obtained from 
three independent observations.Journal of Translational Medicine 2006, 4:12 http://www.translational-medicine.com/content/4/1/12
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cm2 (90 mm diameter) which were redistributed in to 20
non-adherent 90-mm petridishes containing 10 ml of
complete growth medium. The pH of the medium was
monitored daily to prevent acidosis. The medium was
changed on alternative days till spheroids were 14 day
old, followed by redistribution of spheroids from each
petridish further to 10 non-adherent petridishes and the
medium was changed daily thereafter till 28 days. Unlike
other spheroids reported in the literature these spheroids
could not be grown for months as they disintegrated after
28 days.
Spheroid growth measurements
Spheroid growth was monitored by measuring the
increase in spheroid size as a function of time. Images of
spheroids were obtained using the image analysis system
consisting of Olympus BX 60 fluorescence microscope
and Grundig FA87 monochrome CCD camera. Volume
and surface area was calculated using Optimas® image
analysis software (Optimas, USA; version 5.0). The size of
nearly 50 spheroids was evaluated in each group by meas-
uring two orthogonal diameters (d1 and d2) using the
line morphometry function. Volume was calculated using
the formula V = 4/3Πr3, where r = 1/2√ d1d2 the geomet-
ric mean radius. Average cell number per spheroid was
calculated by trypsinizing 10–20 spheroids and the total
number of cells obtained was divided by the number of
spheroids trypsinized.
Analysis of cell cycle kinetics using BrdU labeling
Cells were incubated with 10 µM BrdU for 30 min at 37°C
at various time intervals (7–28 days). Immediately on
completion of incubation, an aliquot containing 106 cells
from monolayers or spheroidal cell suspension was pel-
leted by centrifugation (1000 g, 10 min), resuspended in
PBS, fixed in 80% ethanol and stored at 4°C until use. For
analysis, fixed cells were washed with 0.9% NaCl, incu-
bated with pepsin (0.5% in 0.055 N HCl, pH 1.8) for 10
min at 37°C, washed with saline again, and treated with
2 N HCl for 30 min at room temperature. Following
another wash with normal saline and a wash with PBS-
Tween (0.05%), the cells were incubated with anti-BrdU
antibody (mouse anti-human IgG1; BD Pharmingen,
USA) in PBS-Tween at 1:40 dilution for 30 min at 4°C.
Cells were then washed twice in PBS-Tween (0.05%)-BSA
(1%), and incubated with rabbit antimouse IgG1-FITC
conjugate (Sigma) at 1:100 dilution in PBS-Tween-BSA for
30 min at 4°C. After another wash in PBS-Tween-BSA,
cells were resuspended in PBS and stained with propid-
ium iodide (50 µg/ml) for 30 min. Fluorescence of pro-
pidium iodide (DNA) and FITC (BrdU) was measured
simultaneously in the FACS Calibur Flow Cytometer (Bec-
ton Dickinson), and biparametric scatter plots were ana-
lysed using the CellQuest software. Histograms were
analyzed for cell cycle phase distribution by using Modfit
software.
Detection of PS-externalization using annexin-V labeling
Membrane asymmetry accompanied by translocation of
the phospholipid phosphotidylserine (PS) from inner to
the outer side of the plasma membrane is one of the man-
ifestations of apoptosis. Externalization of PS was studied
by Annexin V (a phospholipid binding protein) binding
assay [22]. Briefly, live cells were washed twice in PBS and
resuspended in binding buffer containing 0.01 M HEPES/
NaOH, pH 7.4; 0.14 mM NaCl; 2.5 mM CaCl2. Cell sus-
pension (1 × 105 cells in 100 µl) in the binding buffer was
incubated with 5 µl of FITC labeled Annexin V (BD
Pharmingen, USA) for 15 minutes in the dark at room
temperature. Following incubation, propidium iodide
was added and fluorescence of cells PI (DNA) and FITC
(Annexin) was measured simultaneously in the FACS Cal-
ibur Flow Cytometer (Becton Dickinson), and biparamet-
ric scatter plots were analysed using the CellQuest
software.
Cell survival
Macrocolony assay with dissociated cell population is still
considered a reference standard for assessing the survival
Mitochondrial status by flow cytometry Figure 8
Mitochondrial status by flow cytometry. Flow cytomet-
ric measurements of mitochondrial mass (a) and activity (b) 
using NAO and Rh123 respectively in the BMG-1 spheroids 
and monolayers. Monolayer (M), 7-day spheroids (7 S), 14-
day spheroids (14 S) and 28-day spheroids (28 S). Inset 
shows average values of the mean fluorescence intensities 
(MFI) of NAO and Rh123 obtained from three independent 
observations.Journal of Translational Medicine 2006, 4:12 http://www.translational-medicine.com/content/4/1/12
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of cells. This has been extensively employed in studies
with ionizing radiation and cytotoxic anticancer drugs, to
predict the dose needed to cure transplanted tumors in
mice as well as multi-cellular spheroids [52,53]. Sphe-
roids and monolayers were washed with PBS and irradi-
ated in HBSS using Co-60 teletherapy source (Theratron-
780 C, Canada) to access the cell survival. Following irra-
diation, spheroids and monolayer cultures were dissoci-
ated into single cells by trypsinization and counted using
haemocytometer. Appropriate number of cells was plated
in 60 mm Petri dishes with complete media containing
10% FCS. Plates were incubated at 37°C in a humidified
incubator (5% CO2  and 95% air) till colonies were
formed (7 days). Methanol fixed colonies was stained
with 1% crystal violet and colonies containing more than
50 cells were scored.
Estimation of glucose utilization and lactate production
BMG-1 cells and spheroids were incubated in HBSS or
HBSS and 2-DG for 2 h. The amount of glucose remaining
unused and the lactate produced were estimated in the
buffer using enzymatic assays. Glucose was measured
using the reducing sugar method [54-56]. Briefly a mix-
ture of equal volumes of incubating medium (HBSS) and
alkaline copper sulphate were incubated at 90°C for 10
minutes, followed by the addition of phosphmolybidic
acid was added at room temperature (~27°C). O.D of the
resulting chromogen was measured at 540 nm. Lactate
was estimated using lactate oxidase method based kit
(Randox; cat No.-LC2389). The number of viable cells in
spheroids was counted and glucose consumed or lactate
produced was normalized with respect to number of via-
ble cells.
Determination of intracellular redox levels
Intracellular redox levels were measured using the fluores-
cent dye H2DCFDA which is a non-polar compound
(Merck England) and yields a fluorescent DCF in the pres-
ence of ROS in the cells. Green fluorescence due to intrac-
ellularly trapped DCF was collected on the FL1 channel on
the log scale. Spheroids and monolayer cells were just
washed twice in PBS and held in PBS with Ca2+, Mg2+,
H2DCFDA (10 µg/ml) and 5 mM glucose, before irradia-
tion and subsequently incubated for half an hour at 37°C.
Cells were trypsinized after a rinse with PBS, washed and
resuspended in PBS with Ca2+, Mg2+ and glucose. Samples
were stored on ice, and measurements were made within
half an hour after trypsinization.
Flow cytometric analysis of mitochondrial mass and 
activity
Spheroids and monolayers were parallely stained with
one of the mitochondrial fluorescent dyes NAO and
Rh123, essentially according to the procedure described
earlier [57]. Briefly, the unfixed spheroids and monolay-
ers were washed and incubated in PBS (with Ca2+, Mg2+),
glucose and NAO (10 µM 10 min at 25°C) or Rh123 (5
µg/ml 30 min. at 37°C), followed by trypsinization wash-
ing and resuspension in PBS (with Ca2+, Mg2+ and glu-
cose) and incubated on ice until analysis by the flow
cytometer.
Preparation of cell extract and western blotting
Scraped monolayer cells and spheroids were collected at
800 g for 5 minutes, washed twice with 5 ml PBS and son-
icated (VC-X 500, Sonics and Materials Inc. USA) on ice in
PBS for 1 minute mixed with pre chilled acetone (3 parts)
and incubated overnight at -20°C. Following incubation,
acetone was removed by centrifugation and pellet was dis-
solved in autoclaved Milli Q water and protein content
was determined by Lowry's method [58]. 2× lysis buffer
[62.5 mM Tris Hcl ph 6.8, 10% (v/v) Glycerol 2% (w/v)
SDS, 1 mM PMSF, 1 µg/ml pepstatin A, 1 µg/ml leupeptin
and 5 µg/ml aprotinin] was added to the pellet and boiled
at 100°C for 5 minutes. An equal amount of protein (10–
20 µg) was loaded on 10% SDS polyacrylamide gels. Pro-
teins were separated at a constant voltage of 100 V for 1.5
hours and then blotted to PVDF membrane (Amersham)
in transfer buffer [25 mM Tris, 192 mM glycine, 15%
methanol (v/v)] overnight at 14 V. The blots were blocked
with 1% BSA in TTBS [15 mM Tris-HCl pH7.5, NaCl .9%
and 0.1% Tween-20] for 1 hour at room temperature (25–
28°C). Membranes were incubated with a mouse mono-
clonal antibody (1:1000) anti Bax (BD Pharmingen,
USA), anti Bcl2 (BD Pharmingen, USA) anti c-Myc (BD
Pharmingen, USA), anti HIF-1α (Santa Cruz Biotechnol-
ogy USA) and anti Beta actin (Promega) for 1 hour in
TTBS and 1% BSA. Membranes were washed with TTBS
four times for 15 minutes each and incubated with anti
mouse peroxidase conjugated secondary antibody
(1:1000 dilutions; Banglore Genei India) for 1 hour. Blots
were washed and developed using ECL chemilumines-
cence detection reagent (Pierce). Membranes were
stripped in stripping buffer (25 mM Glycine, 1% SDS, pH
2 adjusted with HCl) for 1 hour washed twice in TTBS for
10 minutes each and re-probed.
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